International Journal of Cancer · 2004 · 33 citations · 26 references
Life SciencesMolecular BiologyOncologyCancer GeneticsDna RepairGene ExpressionApoptosis In CancerBrain TumorsCancer GenomicsCancer Molecular PathologyCancer TranscriptomicsMolecular Classification Of TumorsAstrocytoma PathologyBrain Tumor PathologyCancer-associated SplicingOncogene Expression AnalysisOncogenic SplicingPrimary Brain NeoplasmsSomatic Mutations
The ING1 family of proteins has been shown to have regulatory functions in oncogenesis, apoptosis, DNA repair and cell cycle regulation. Here we present the first report on LOH analysis of the ING1 locus, mutation analysis of the complete coding sequence including intron-exon boundaries and expression analysis of the different ING1 splice products and protein isoforms in primary brain tumours. No somatic ING1 mutations were detected. Semi-quantitative analysis revealed higher levels of p33ING1b RNA in benign than in malignant lesions. This correlation was significant in a subset of 37 astrocytic tumours WHO grades I to IV. ING1 protein isoforms p47ING1a, p33ING1b and p24ING1c were found to be expressed variably in this series. Our findings support a regulatory contribution of ING1 to the development or progression of brain tumours.
26
Pathology and Genetics of Tumours of the Nervous System
Michael Brada · British Journal of Cancer · 2001 · 793 citations · Full text
The candidate tumour suppressor p33ING1cooperates with p53 in cell growth control
Igor Garkavtsev, Irina A. Grigorian, Valeria Ossovskaya et al. · Nature · 1998 · 294 citations
The retinoblastoma gene is involved in malignant progression of astrocytomas
John W. Henson, Bernd L. Schnitker, Katia M. Correa et al. · Annals of Neurology · 1994 · 219 citations